Photo |
Details |
Speaker |
Organization |
Speech Title |
|
Jan 12
2:30-3:30pm
PSC 124 |
Dr. Michael Harris |
Case Western Reserve University; School of Medicine |
Integration of Theory and Experiment to Determine Ribonuclease Mechanism |
|
Feb 9
2:30-3:30pm
PSC 124 |
Dr. Dan Cox |
Georgia State University; Neuroscience Institute |
Cellular and Molecular Mechanisms of Thermosensory Nociception and Multimodal Sensory Processing |
|
Mar 1
2:30-3:30pm
PSC 124 |
Dr. Christian Melander |
North Carolina State University |
Small Molecule Regulation of Antibiotic Resistance |
|
Mar 8
2:30-3:30pm
PSC 124 |
Dr. Bingzhong Xue |
Georgia State University; Center for Diagnostics and Therapeutics |
Targeting Brown/Beige Adipocytes in Obesity Treatment |
|
Mar 22
2:30-3:30pm
PSC 124 |
Dr. Kah Whye Peng |
Mayo Clinic |
Virotherapy for Cancer |
|
Apr 19
2:30-3:30pm
PSC 362 |
Dr. Jamey Weichert |
University of Wisconsin; School of Medicine and Public Health |
Phospholipid Ethers: A Broad Spectrum Cancer Imaging and Therapy Delivery Platform |
|
May 10
2:30-3:30pm
PSC 124 |
Dr. William Hopkins |
Georgia State University; Neuroscience Institute |
Chimpanzees as a Model Species for the Study of Neural and Genetic Mechanisms Underlying Autism-related Phenotypes |
|
Jun 7
2:30-3:30pm
PSC 124 |
Dr. Georgia Chen |
Emory University; School of Medicine |
Optimizing EGFR-Based Targeted Therapy for Cancer Treatment |
|
Jun 28
2:30-3:30pm
PSC 124 |
Dr. Angelika Niemz |
Keck Graduate Institute |
Integrated Nucleic Acid Testing for TB diagnosis in Peripheral Settings |
|
Aug 16
2:30-3:30pm
PSC 124 |
Dr. Wang Ya |
Emory University; Winship Cancer Institute |
MicroRNA and DNA Damage Response |